Respirogen developing novel technology for Acute Respiratory Distress Syndrome as a result of COVID-19 - Colorado Bioscience Association

This topic is empty.

Viewing 1 post (of 1 total)

Author

Posts
04/01/2020 at 2:43 pm #4109

Colorado BioScience Association
Keymaster

Respirogen is developing a novel technology for therapeutic oxygen delivery for treatment of patients suffering from Acute Respiratory Distress Syndrome as a result of COVID-19. The technology could also be used as a potential ventilator substitute in overloaded health care systems.
Author

Posts

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.